Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement

• Published in: Modern pathology 2017-03, Vol.30 (3), p.416-426
• Main Authors: Xia, Qiu-yuan, Wang, Zhe, Chen, Ni, Gan, Hua-lei, Teng, Xiao-dong, Shi, Shan-shan, Wang, Xuan, Wei, Xue, Ye, Sheng-bing, Li, Rui, Ma, Heng-hui, Lu, Zhen-feng, Zhou, Xiao-jun, Rao, Qiu
• Format: Article
• Language: English
• Subjects: 38/32; 45/23; 45/90; 631/208/68; 631/67/589/1588/1351; Adult; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - genetics; Carcinoma, Renal Cell - genetics; Carcinoma, Renal Cell - pathology; DNA-Binding Proteins; Female; Gene Rearrangement; Genes; Hospitals; Humans; Kidney cancer; Kidney Neoplasms - genetics; Kidney Neoplasms - pathology; Laboratory Medicine; Male; Medical prognosis; Medicine; Medicine & Public Health; Middle Aged; Morphology; Nuclear Matrix-Associated Proteins - genetics; Octamer Transcription Factors - genetics; Oncogene Fusion; original-article; Pathology; Prognosis; RNA-Binding Proteins - genetics; Tumors; Young Adult
• ISSN: 0893-3952; 1530-0285
• DOI: 10.1038/modpathol.2016.204

Xp11 translocation renal cell carcinomas are characterized by several different translocations involving the TFE3 gene. Tumors with different specific gene fusions may have different clinicopathological manifestations. Fewer than 10 renal cell carcinoma cases with NONO-TFE3 have been described. Here we examined eight additional cases of this rare tumor using clinicopathological, immunohistochemical, and molecular analyses. The male-to-female ratio of our study cohort was 1:1, and the median age was 30 years. The most distinctive feature of the tumors was that they exhibited glandular/tubular or papillary architecture that was lined with small-to-medium cuboidal to high columnar cells with indistinct cell borders and an abundantly clear or flocculent eosinophilic cytoplasm. The nuclei were oriented toward the luminal surface and were round and uniform in shape, which resulted in the appearance of secretory endometrioid subnuclear vacuolization. The distinct glandular/tubular or papillary architecture was often accompanied by sheets of epithelial cells that presented a biphasic pattern. Immunohistochemically, all eight cases demonstrated moderate (2+) or strong (3+) positive staining for TFE3, CD10, RCC marker, and PAX-8. None of the tumors were immunoreactive for CK7, Cathepsin K, Melan-A, HMB45, Ksp-cadherin, Vimentin, CA9, 34βE12 or CD117. NONO-TFE3 fusion transcripts were identified in six cases by RT-PCR. All eight cases showed equivocal split signals with a distance of nearly 2 signal diameters and sometimes had false-negative results. Furthermore, we developed a fluorescence in situ hybridization (FISH) assay to serve as an adjunct diagnostic tool for the detection of the NONO-TFE3 fusion gene and used this method to detect the fusion gene in all eight cases. Long-term follow-up (range, 10–102 months) was available for 7 patients. All 7 patients were alive with no evidence of recurrent disease or disease progression after their initial resection. This report adds to the known data regarding NONO-TFE3 renal cell carcinoma.